Concentric Capital Strategies LP Increases Holdings in Danaher Co. (NYSE:DHR)

Concentric Capital Strategies LP boosted its position in Danaher Co. (NYSE:DHR) by 203.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,182 shares of the conglomerate’s stock after purchasing an additional 4,815 shares during the period. Concentric Capital Strategies LP’s holdings in Danaher were worth $1,997,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of DHR. Lynx Investment Advisory purchased a new stake in shares of Danaher in the 2nd quarter worth about $63,000. Harbor Capital Advisors Inc. raised its position in Danaher by 8.3% during the second quarter. Harbor Capital Advisors Inc. now owns 11,505 shares of the conglomerate’s stock worth $2,875,000 after acquiring an additional 879 shares during the last quarter. Park Avenue Securities LLC lifted its holdings in shares of Danaher by 2.3% in the second quarter. Park Avenue Securities LLC now owns 25,551 shares of the conglomerate’s stock valued at $6,384,000 after purchasing an additional 581 shares in the last quarter. CWM LLC grew its position in shares of Danaher by 5.1% in the second quarter. CWM LLC now owns 23,034 shares of the conglomerate’s stock valued at $5,755,000 after purchasing an additional 1,122 shares during the last quarter. Finally, Valeo Financial Advisors LLC increased its stake in shares of Danaher by 5.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 14,053 shares of the conglomerate’s stock worth $3,511,000 after purchasing an additional 729 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. UBS Group reduced their target price on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Evercore ISI upped their price objective on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Wells Fargo & Company assumed coverage on Danaher in a research report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price objective for the company. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a report on Thursday, October 31st. Finally, Barclays decreased their price target on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Price Performance

Shares of Danaher stock opened at $241.27 on Tuesday. The stock has a market capitalization of $174.26 billion, a P/E ratio of 46.04, a PEG ratio of 4.41 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The business’s fifty day moving average price is $254.59 and its 200 day moving average price is $259.41. Danaher Co. has a twelve month low of $215.68 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the previous year, the business earned $2.02 EPS. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. As a group, research analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher’s dividend payout ratio (DPR) is 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.